Table 5.
Prevalence of antimicrobial resistance among 70 E. coli isolates from 6 bitches suffering pyometra.
| Antimicrobial drug | Uteri (pus) (n = 25) |
Mouth (saliva) (n = 26) |
Rectum (feces) (n = 19) |
|---|---|---|---|
| Norfloxacin | 0* (0.0%)** | 5 (19.2%) | 1 (5.2%) |
| Cefoxitin | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Tobramycin | 0 (0.0%) | 7 (26.9%) | 6 (31.5%) |
| Ciprofloxacin | 2 (8.0%) | 1 (3.8%) | 2 (10.5%) |
| Gentamicin | 3 (12.0%) | 6 (23.0%) | 5 (26.3%) |
| Ceftriaxone | 5 (20.0%) | 5 (19.2%) | 7 (36.8%) |
| Tetracycline | 8 (32.0%) | 22 (84.6%) | 12 (63.1%) |
| Amikacin | 10 (40.0%) | 10 (38.4%) | 11 (57.8%) |
| Nitrofurantoin | 10 (40.0%) | 16 (61.5%) | 15 (78.9%) |
| Ampicillin | 14 (56.0%) | 22 (84.6%) | 9 (47.3%) |
| Nalidixic acid | 14 (56.0%) | 22 (84.6%) | 8 (42.1%) |
| Cephalothin | 17 (68.0%) | 17 (65.3%) | 13 (68.4%) |
*Number of isolates; **percentage.